UncategorizedRejuvant leads longevity pack with significant biologic age reduction – Longevity.Technology Empower Meds / November 20, 2025
UncategorizedCognition Therapeutics secures FDA alignment for Phase 3 registrational plan – Longevity.Technology Empower Meds / November 20, 2025
UncategorizedGameto raises $44 M in Series C, begins pivotal Phase 3 trial – Longevity.Technology Empower Meds / November 20, 2025
UncategorizedSeal Rock Therapeutics joins the Michael J. Fox Foundation’s LITE program – Longevity.Technology Empower Meds / November 20, 2025
UncategorizedPhotoPharmics expands enrollment beyond 300 in groundbreaking PD trial – Longevity.Technology Empower Meds / November 20, 2025
UncategorizedGroundbreaking Fatty15 boosts Seraphina Therapeutics on Inc. 5000 list – Longevity.Technology Empower Meds / November 20, 2025
UncategorizedPfizer Ventures’ Michael Baran joins Sapien Capital’s DeSci push Empower Meds / November 20, 2025
UncategorizedLongevity.Technology announces Longevity Clinics World launch Empower Meds / November 20, 2025
UncategorizedGameto lands $44m to advance fertility and menopause programs Empower Meds / November 20, 2025
UncategorizedBiotech lands $35m to combat cognitive decline with ‘longevity protein’ Empower Meds / November 20, 2025
